ArticleScientific reports2026
Biosynthesis of silver nanoparticles via Melaleuca alternifolia leaf extract for antibacterial, antifungal, antioxidant and anticancer activity.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioengineered Silver Nanoparticles: Next-Generation Biogenic Synthesis Strategies for Precision Biomedical Applications.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthesis of silver nanoparticles using the leaf extract of Melaleuca alternifolia (M-AgNPs), as evidenced by various physicochemical characterizations, including UV-Visible spectroscopy (UV-Vis), Fourier-transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-ray analysis (EDAX), high-resolution transmission electron microscopy (HR-TEM), and zeta potential analysis. The UV-Vis spectrum exhibited a characteristic absorption peak at 402 nm, confirming the formation of M-AgNPs. FT-IR analysis identified the presence of various functional groups associated with the silver nanoparticles. DLS measurements indicated a hydrodynamic size of 45.79 nm with a polydispersity index (PDI) of 0.335. Zeta potential analysis revealed a value of -21 mV, suggesting good stability of the nanoparticles. XRD analysis showed a crystalline size of 25.47 nm and confirmed the face-centered cubic (FCC) structure. SEM images revealed well-defined and uniformly dispersed nanoparticles. EDAX confirmed the presence of silver at the elemental level. HR-TEM analysis demonstrated that the actual size of the nanoparticles was approximately 10 nm. Antimicrobial studies demonstrated the effectiveness of the synthesized nanoparticles against both bacterial and fungal strains. The antioxidant activity of the M-AgNPs was measured at 41.17 µL/mL. Furthermore, cytotoxicity studies showed that the nanoparticles exhibited an IC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.